Search - tctmd.com

Displaying 61 - 80 of 8900

Sort: Relevancy | Date

Presentation TCT 2025

Effects of Intracoronary Low-Dose Recombinant Tissue Plasminogen Activator as an Adjunct to Primary PCI in Patients with STEMI and Large Thrombus Burden: A Randomized, Double-Blind, Placebo-Controlled Trial

Presenter: Shamir R. Mehta

October 28, 2025

Presentation TCT 2025

Commentary

Presenter: Subhash Banerjee

October 28, 2025

Presentation TCT 2025

Percutaneous Coronary Intervention of Native Coronary Artery versus Saphenous Vein Graft in Patients with Prior Coronary Artery Bypass Graft Surgery (PROCTOR): A Multicenter, Open-label, Randomized Trial

Presenter: Ruben W. de Winter

October 28, 2025

Presentation TCT 2025

Robotically Assisted M-TEER With SurgiPulse Technology: Early Procedural and Clinical Insights of the Randomized Controlled Trial

Presenter: Luigi Pirelli

October 28, 2025

Presentation TCT 2025

TTVI: Updates from Clinical Trials and Registries

Presenter: Jörg Hausleiter

October 28, 2025

Presentation TCT 2025

Should Sham Control vs Open Trial Design Make a Difference for Device Regulators and Guideline Makers?

Presenter: Gregg W. Stone

October 28, 2025

News Conference News TCT 2025

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

Todd Neale

October 27, 2025

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

News Conference News TCT 2025

Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC

Yael L. Maxwell

October 27, 2025

News Conference News TCT 2025

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

Caitlin E. Cox

October 27, 2025

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

Presentation TCT 2025

Leverage Artificial Intelligence in Clinical Trials: Opportunities and Challenges

Presenter: Alexandra Popma

October 27, 2025

Presentation TCT 2025

The Challenges of Recurrent Event Models and Multiple Endpoints

Presenter: Daniele Giacoppo

October 27, 2025

Presentation TCT 2025

TCT 711: Outcomes of Left Atrial Appendage Closure vs. Oral Anticoagulation Following Catheter Ablation in Older and Younger Patients: A Sub-analysis of the OPTION Clinical Trial

Presenter: Devi G. Nair

October 27, 2025

Presentation TCT 2025

Estimands: Clarifying What We’re Measuring in Clinical Trials

Presenter: Roseann M. White

October 27, 2025

Presentation TCT 2025

Pragmatic, Adapted, and Augmented Trials: Ready for Regulatory Approval

Presenter: Sreekanth Vemulapalli

October 27, 2025

Presentation TCT 2025

Current Trials to Extend LAAC Clinical Indications

Presenter: Shephal K. Doshi

October 27, 2025

Presentation TCT 2025

Joint Modelling for Death and Quality of Life: Worthy as a Primary Endpoint

Presenter: John A. Spertus

October 27, 2025

Presentation TCT 2025

Placebo-Controlled Interventional Trials: A Sham No More

Presenter: Rasha Al-Lamee

October 27, 2025

Presentation TCT 2025

TCT 919: Representation of Resuscitated Out of Hospital Cardiac Arrest Patients in Landmark Cardiogenic Shock Clinical Trials - a Simulated Cohort Study

Presenter: Hugh Lurcott

October 27, 2025

Advertisement

Effects of Intracoronary Low-Dose Recombinant Tissue Plasminogen Activator as an Adjunct to Primary PCI in Patients with STEMI and Large Thrombus Burden: A Randomized, Double-Blind, Placebo-Controlled Trial

Commentary

Percutaneous Coronary Intervention of Native Coronary Artery versus Saphenous Vein Graft in Patients with Prior Coronary Artery Bypass Graft Surgery (PROCTOR): A Multicenter, Open-label, Randomized Trial

Robotically Assisted M-TEER With SurgiPulse Technology: Early Procedural and Clinical Insights of the Randomized Controlled Trial

TTVI: Updates from Clinical Trials and Registries

Should Sham Control vs Open Trial Design Make a Difference for Device Regulators and Guideline Makers?

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Leverage Artificial Intelligence in Clinical Trials: Opportunities and Challenges

The Challenges of Recurrent Event Models and Multiple Endpoints

TCT 711: Outcomes of Left Atrial Appendage Closure vs. Oral Anticoagulation Following Catheter Ablation in Older and Younger Patients: A Sub-analysis of the OPTION Clinical Trial

Estimands: Clarifying What We’re Measuring in Clinical Trials

Pragmatic, Adapted, and Augmented Trials: Ready for Regulatory Approval

Current Trials to Extend LAAC Clinical Indications

Joint Modelling for Death and Quality of Life: Worthy as a Primary Endpoint

Placebo-Controlled Interventional Trials: A Sham No More

TCT 919: Representation of Resuscitated Out of Hospital Cardiac Arrest Patients in Landmark Cardiogenic Shock Clinical Trials - a Simulated Cohort Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content